Generics 37

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Melphalan manufacturers

37 products found

Filters

37 products found

melphalan

Concentrate for solution for infusion 90 mg/ml - 1 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #614
A pharmaceutical manufacturer based in Europe selling its products in Europe and worldwide for 10+ years. Main dosage forms include injectable and oral dosage forms. The company's production lines are EU GMP-compliant. The main therapeutic area is oncology.

Manufacturer usually replies in 7 days

melphalan

Powder and solvent for solution for infusion 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica , Serbia , United Kingdom
Registered in
Austria , Germany , United Kingdom
Manufacturer #1338

Manufacturer usually replies in 7 days

melphalan

Tablets 2mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #403

melphalan

Vials, injection 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
FDA, EU GMP, ANVISA, INVIMA
Unavailable markets
Turkey , Brazil , Mexico , Vietnam
Registered in
Yu , Costa Rica , Iran , Dominica
Available for
Licensing with supply, Distribution only
Manufacturer #11475
The company is situated in South America and over time has expanded producing oncology drugs for Latin America, Asia Pacific, Europe, and North America, including the United States. The goal of the company is to develop and produce high-quality oncology generics and generics with value-added technology or super generics. Part of the goal is also to produce efficient processes that allow us to have competitive prices.

Manufacturer usually replies in 4 days

melphalan

Injection, lyophilized 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 5 days

melphalan

Tablets 2 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

melphalan

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

melphalan

Tablets 2 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

melphalan

Tablets 2 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

melphalan

Injection, lyophilized 50 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Comments
Dossier availability date: Q3 2024
Manufacturer #2760

Manufacturer usually replies in 5 days

melphalan

Vials, lyophilized injection 50 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

melphalan

Tablets 2 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

melphalan

Tablets 2 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19670

Manufacturer usually replies in 8 days

melphalan

Injection 2 mg, 5 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

melphalan

Tablets 2 mg, 5 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

melphalan

Tablets 2 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17691

Manufacturer usually replies in 7 days

melphalan

Tablets 2mg, 5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

melphalan

Solution for injection/infusion 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

melphalan

Tablets, film coated 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina, Brazil, Pakistan, Paraguay, Peru, Uruguay, WHO, PICS
Unavailable markets
Argentina , Brazil , Chile , Ecuador , Paraguay , Peru , Uruguay
Manufacturer #16112

Manufacturer usually replies in 6 days

melphalan

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Registered in
India
Available for
Distribution only
MAs for sale
India
Manufacturer #21337

Manufacturer usually replies in 11 days

Want to view all 37 products? Create your free account today!

Melphalan Manufacturers

Melphalan is an antineoplastic drug. It belongs to a drug group called alkylating agents. These agents prevent the double helix of the DNA to link together both strands. As a result, cancer cells can no longer multiply, and they die eventually. These alkylating agents do so by attaching an alkyl group to the DNA’s guanine base. The chemical name of Melphalan is Melphalan Hydrochloride. Its trade names are Alkeran, Evomela, and Phelinun etc.

How it Works

- Melphalan is an effective medication for various types of cancer. In all types of cancers, there is an abnormal growth of unwanted cells, which spread to other parts of the body. Melphalan helps prevent cancer cells from multiplying by changing DNA and RNA chemically. Through its alkylation process, it breaks linkages of the strands of DNA and RNA. Hence, the synthesis process of DNA and RNA is stopped and therefore cancer cells start dying.

It is used to Treat

- Melphalan is used for the treatment of multiple myeloma, which is also known as bone marrow cancer. It can also be used for ovarian cancer and melanoma. Ovarian cancer is a type of cancer due to which there is an abnormal growth of cells in the ovary.

Dosage

- Melphalan can be taken by mouth as a tablet, or it can be injected into the veins by the doctor. It should be taken only once a day with an empty stomach. It is better to consult the doctor because he/she knows your medical condition and response to treatment.

Price of Melphalan

Depending on the pharmacy, Melphalan intravenous injection 50 mg cost approx $257 for a supply of one injection. However, Melphalan is also available as a tablet form which costs $20 for ten tablets.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Melphalan offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Melphalan manufacturers and Melphalan suppliers that you are looking for. These also enable you to check the dossier status of Melphalan and the GMP approvals of the different variants of Melphalan Also, each manufacturer or supplier product description contains essential information about Melphalan including clinical data, stability zones, countries where Melphalan is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Melphalan offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Melphalan manufacturers list has, we qualify their companies before they are on boarded on the platform. This allows us to screen Melphalan manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.